A joint model of persistent human papilloma virus infection and cervical cancer risk: Implications for cervical cancer screening

Journal of the Royal Statistical Society. Series A: Statistics in Society

Volumn 178, Issue 4, 2015, Pages 903-923

  Katki, Hormuzd A ^a   Cheung, Li C ^b   Fetterman, Barbara ^c   Castle, Philip E ^d   Sundaram, Rajeshwari ^e  

^a NATIONAL CANCER INSTITUTE   (United States)

^b INFORMATION MANAGEMENT SERVICES INC   (United States)

^c KAISER PERMANENTE   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e Eunice Kennedy Shriver National Institutes of Child Health and Human Development   (United States)

Author keywords

Cancer screening; Human papilloma virus; Joint modelling of longitudinal and survival data; Medical guidelines; Risk modelling

Indexed keywords

EID: 84942337366     PISSN: 09641998     EISSN: 1467985X     Source Type: Journal    
DOI: 10.1111/rssa.12101     Document Type: Article

References (37)

1. Armitage, P. and Doll, R. (1954) The age distribution of cancer and a multi-stage theory of carcinogenesis. Br. J. Cancer, 8, 1-12.
2. Bellamy, S. L., Li, Y., Ryan, L. M., Lipsitz, S., Canner, M. J. and Wright, R. (2004) Analysis of clustered and interval censored data from a community-based study in asthma. Statist. Med., 23, 3607-3621.
3. Carozzi, F., Gillio-Tos, A., Confortini, M., Del Mistro, A., Sani, C., De Marco, L., Girlando, S., Rosso, S., Naldoni, C., Dalla Palma, P., Zorzi, M., Giorgi-Rossi, P., Segnan, N., Cuzick, J., Ronco, G. and NTCC Working Group (2013) Risk of high-grade cervical intraepithelial neoplasia during follow-up in hpv-positive women according to baseline p16-ink4a results: a prospective analysis of a nested substudy of the NTCC randomised controlled trial. Lancet Oncol., 14, 168-176.
4. Cuzick, J., Arbyn, M., Sankaranarayanan, R., Tsu, V., Ronco, G., Mayrand, M.-H., Dillner, J. and Meijer, C. J. L. M. (2008) Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine, 26, suppl. 10, K29-K41.
5. Diggle, P., Liang, K.-Y. and Zeger, S. L. (1994) Analysis of Longitudinal Data. Oxford: Oxford University Press.
6. Gage, J. C., Katki, H. A., Schiffman, M., Fetterman, B., Poitras, N. E., Lorey, T., Cheung, L. C., Castle, P. E. and Kinney, W. K. (2014) Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection. Int. J. Cancer, to be published, doi 10.1002/ijc.29143.
7. Hougaard, P (2000) Analysis of Multivariate Survival Data. Berlin: Springer.
8. Huang, X., Stefanski, L. A. and Davidian, M. (2009) Latent-model robustness in joint models for a primary endpoint and a longitudinal process. Biometrics, 65, 719-727.
9. Katki, H. A., Kinney, W. K., Fetterman, B., Lorey, T., Poitras, N. E., Cheung, L., Demuth, F., Schiffman, M., Wacholder, S. and Castle, P. E. (2011) Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol., 12, 663-672.
10. Katki, H. A., Schiffman, M., Castle, P. E., Fetterman, B., Poitras, N. E., Lorey, T., Cheung, L. C., Raine-Bennett, T., Gage, J. C. and Kinney, W. K. (2013a) Benchmarking CIN 3+ risk as the basis for incorporating HPV and Pap cotesting into cervical screening and management guidelines. J. Low Genit. Tract Dis., 17, suppl. 1, S28-S35.
11. Katki, H. A., Schiffman, M., Castle, P. E., Fetterman, B., Poitras, N. E., Lorey, T., Cheung, L. C., Raine-Bennett, T., Gage, J. C. and Kinney, W. K. (2013b) Five-year risks of CIN 3+ and cervical cancer among women who test Pap-negative but are HPV-positive. J. Low Genit. Tract Dis., 17, suppl. 1, S56-S63.
12. Kirby, A. J. and Spiegelhalter, D. J. (1994) Modeling the precursors of cervical cancer. In Case Studies in Biometry (eds N. Lange, L. Ryan, L. Billard, D. Brillinger, L. Conquest and J. Greenhouse), pp. 359-383. New York: Wiley-Interscience.
13. Kong, X., Gray, R. H., Moulton, L. H., Wawer, M. and Wang, M.-C. (2010) A modeling framework for the analysis of HPV incidence and persistence: a semi-parametric approach for clustered binary longitudinal data analysis. Statist. Med., 29, 2880-2889.
14. Leeson, S. C., Alibegashvili, T., Arbyn, M., Bergeron, C., Carriero, C., Mergui, J.-L., Nieminen, P., Prendiville, W., Redman, C. W., Rieck, G. C., Quaas, J. and Petry, K. U. (2013) HPV testing and vaccination in Europe. J. Low Genit. Tract Dis., 18, 61-69.
15. Lindsey, J. K. (1998) A study of interval censoring in parametric regression models. Liftim. Data Anal., 4, 329-354.
16. Massad, L. S., Einstein, M. H., Huh, W. K., Katki, H. A., Kinney, W. K., Schiffman, M., Solomon, D., Wentzensen, N. and Lawson, H. W. (2013) 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J. Low Genit. Tract Dis., 17, suppl. 1, S1-S27; correction, 17 (2013), 367.
17. Mirabello, L., Sun, C., Ghosh, A., Rodriguez, A. C., Schiffman, M., Wentzensen, N., Hildesheim, A., Herrero, R., Wacholder, S., Lorincz, A. and Burk, R. D. (2012) Methylation of human papillomavirus type 16 genome and risk of cervical precancer in a Costa Rican population. J. Natn. Cancer Inst., 104, 556-565.
18. Mitchell, C. E., Hudgens, M. G., King, C. C., Cu-Uvin, S., Lo, Y., Rompalo, A., Sobel, J. and Smith, J. S. (2011) Discrete-time semi-markov modeling of human papillomavirus persistence. Statist. Med., 30, 2160-2170.
19. Plummer, M., Schiffman, M., Castle, P. E., Maucort-Boulch, D., Wheeler, C. M. and ALTS Group (2007) A 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion. J. Infect. Dis., 195, 1582-1589.
20. Proust-Lima, C. and Taylor, J. M. G. (2009) Development and validation of a dynamic prognostic tool for prostate cancer recurrence using repeated measures of posttreatment psa: a joint modeling approach. Biostatistics, 10, 535-549.
21. Rizopoulos, D. (2011) Dynamic predictions and prospective accuracy in joint models for longitudinal and time-to-event data. Biometrics, 67, 819-829.
22. Rizopoulos, D. (2012) Joint Models for Longitudinal and Time-to-event Data. Boca Raton: CRC Press.
23. Rizopoulos, D., Verbeke, G. and Molenberghs, G. (2010) Multiple-imputation-based residuals and diagnostic plots for joint models of longitudinal and survival outcomes. Biometrics, 66, 20-29.
24. Rodriguez, A. C., Schiffman, M., Herrero, R., Hildesheim, A., Bratti, C., Sherman, M. E., Solomon, D., Guilln, D., Alfaro, M., Morales, J., Hutchinson, M., Katki, H., Cheung, L., Wacholder, S. and Burk, R. D. (2010) Longitudinal study of human papillomavirus persistence and cervical intraepithelial neoplasia grade 2/3: critical role of duration of infection. J. Natn. Cancer Inst., 102, 315-324.
25. Rodriguez, A. C., Schiffman, M., Herrero, R., Wacholder, S., Hildesheim, A., Castle, P. E., Solomon, D., Burk, R. and Proyecto Epidemilógico Guanecaste Group(2008) Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections. J. Natn. Cancer Inst., 100, 513-517.
26. Schiffman, M., Castle, P. E., Jeronimo, J., Rodriguez, A. C. and Wacholder, S. (2007) Human papillomavirus and cervical cancer. Lancet, 370, 890-907.
27. Schiffman, M., Safaeian, M. and Wentzensen, N. (2009) The use of human papillomavirus seroepidemiology to inform vaccine policy. Sex Transm. Dis., 36, 675-679.
28. Song, X., Davidian, M. and Tsiatis, A. A. (2002) A semiparametric likelihood approach to joint modeling of longitudinal and Time-to-event data. Biometrics, 58, 742-753.
29. Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N. B., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., McBride, P., Schwartz, J. S., Shero, S. T., Smith, Jr, S. C., Watson, K., Wilson, P. W., Eddleman, K. M., Jarrett, N. M., LaBresh, K., Nevo, L., Wnek, J., Anderson, J. L., Halperin, J. L., Albert, N. M., Bozkurt, B., Brindis, R. G., Curtis, L. H., DeMets, D., Hochmans, J. S., Kovacs, R. J., Ohman, E. M., Pressler, S. J., Sellke, F. W., Shen, W. K., Smith, Jr, S. C., Tomaselli, G. F. and American College of Cardiology/American Heart Association Task Force on Practice Guidelines. (2013) 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 129, suppl. 2, S1-S45; correction, 129 (2014), suppl. 2, S46-S48.
30. Sweeting, M. J. and Thompson, S. G. (2011) Joint modelling of longitudinal and time-to-event data with application to predicting abdominal aortic aneurysm growth and rupture. Biometr. J., 53, 750-763.
31. Sweeting, M. J. and Thompson, S. G. (2012) Making predictions from complex longitudinal data, with application to planning monitoring intervals in a national screening programme. J. R. Statist. Soc. A, 175, 569-586.
32. Taylor, J. M. G., Park, Y., Ankerst, D. P., Proust-Lima, C., Williams, S., Kestin, L., Bae, K., Pickles, T. and Sandler, H. (2013) Real-time individual predictions of prostate cancer recurrence using joint models. Biometrics, 69, 206-213.
33. Turnbull, B. W. (1976) The empirical distribution function with arbitrarily grouped censored and truncated data. J. R. Statist. Soc. B, 38, 290-295.
34. Verbeke, G. and Lesaffre, E. (1996) A linear mixed-effects model with heterogeneity in the random-effects population. J. Am. Statist. Ass., 91, 217-221.
35. Verbeke, G. and Molenberghs, G. (2013) The gradient function as an exploratory goodness-of-fit assessment of the random-effects distribution in mixed models. Biostatistics, 14, 477-490.
36. Wolfinger, R. D. (1999) Fitting non-linear mixed models with the new NLMIXED procedure. In Proc. 24th SAS Users Group Int. Conf., paper 287.
37. Wu, M. and Carroll, R. (1988) Estimation and comparison of changes in the presence of informative right censoring by modeling the censoring process. Biometrics, 44, 175-188.